Abstract
Pancreatic cancer is one of the most life-threatening neoplasias and its prognosis has not been improved despite advances in diagnostic and therapeutic strategies. Because the disease is usually diagnosed at advanced tumor stages, patients have a median survival of <1 year; only 5% of patients are alive 5 years after diagnosis. The main reasons for these findings are resistance against co…